FDA Strengthens Heart Attack, Stroke Warnings On Popular Painkillers
the Clinical Pain Advisor take:
The Food and Drug Administration (FDA) is now requiring tougher language on warning labels for popular painkillers. The agency now wants users to understand how heart attacks and stroke can occur within the first few weeks of taking prescription and over-the-counter (OTC) nonsteroidal anti-inflammatory drugs (NSAIDs).
Found on the FDA's website:
"The labels for both prescription NSAIDs and OTC NSAIDs already have information on heart attack and stroke risk. In the coming months, FDA will require manufacturers of prescription NSAIDs to update their labels with more specific information about heart attack and stroke risks. FDA will also request that the manufacturers of OTC NSAIDs update the heart attack and stroke risk information in Drug Facts labels."
What's causing the change in policy? The FDA added a boxed warning to prescription drug labels for this heart attack and stroke risk in 2005. With regard to NSAID labeling, the FDA said it decided to make changes because there's now more data and information available on this topic.
Individuals who have cardiovascular disease, specifically those who've recently had cardiac bypass surgery or a heart attack, are at the greatest risk -- but that doesn't mean this is only the case for this population in particular.
“Everyone may be at risk -- even people without an underlying risk for cardiovascular disease,” said Judy Racoosin, MD, MPH., deputy director of FDA’s Division of Anesthesia, Analgesia, and Addiction Products, in a statement.
The FDA is now requiring tougher language in warning labels for popular painkillers.
Clinical Pain Advisor Articles
- Supervised Injection Sites: Facts, Information, Pros, and Cons
- Chronic Pain May Be a Contributing Factor to Suicide
- Striking a Balance Between Opioid Surveillance and Patient Privacy
- Demographic Characteristics of Pregnant Women With Opioid Use Disorder
- Effects of Mindfulness Therapy, Pharmacologic Prophylaxis on Catecholamine Levels in Migraine
- Perioperative Pain Management in Patients With Opioid Use Disorder
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- Antidepressant Effects of Ketamine Appear to Require Opioid System Activation
- Reviewing the Efficacy of Intrathecal Morphine, Ziconotide for Cancer- and Noncancer Chronic Pain
- Seven-Item Pain Intensity Measure Reliable in Individuals With Dementia
- Factors Associated With Suboptimal Interscalene Brachial Plexus Block for Arthroscopy
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- Scholarship Support Limited for Veterans Enrolling in MD Programs
- Alpha and Beta Band Activity in MS-Related Chronic Pain
- New Opioid-Induced Constipation Management Guidelines Available